Ralliant Corporation (NYSE:RAL) Sees Large Growth in Short Interest

Ralliant Corporation (NYSE:RAL) was the recipient of a significant growth in short interest in January. As of January 30th, there was short interest totaling 3,747,948 shares, a growth of 58.7% from the January 15th total of 2,361,505 shares. Approximately 3.3% of the shares of the stock are sold short. Based on an average daily trading volume, of 1,494,198 shares, the short-interest ratio is presently 2.5 days. Based on an average daily trading volume, of 1,494,198 shares, the short-interest ratio is presently 2.5 days. Approximately 3.3% of the shares of the stock are sold short.

Analysts Set New Price Targets

A number of analysts have commented on RAL shares. Citigroup reduced their price objective on shares of Ralliant from $61.00 to $51.00 and set a “buy” rating for the company in a research note on Friday, February 6th. Zacks Research lowered shares of Ralliant from a “hold” rating to a “strong sell” rating in a research note on Monday, February 9th. Barclays lowered their price objective on shares of Ralliant from $60.00 to $52.00 and set an “overweight” rating on the stock in a research report on Monday, February 9th. Royal Bank Of Canada decreased their target price on Ralliant from $52.00 to $41.00 and set a “sector perform” rating for the company in a research report on Friday, February 6th. Finally, Morgan Stanley reiterated an “overweight” rating and set a $45.00 price target on shares of Ralliant in a report on Friday, February 6th. Seven equities research analysts have rated the stock with a Buy rating, three have issued a Hold rating and two have issued a Sell rating to the stock. According to MarketBeat, the company currently has a consensus rating of “Hold” and a consensus target price of $50.50.

Insider Buying and Selling at Ralliant

In other Ralliant news, Director Kate Mitchell purchased 2,350 shares of the firm’s stock in a transaction on Tuesday, February 10th. The shares were purchased at an average price of $42.48 per share, for a total transaction of $99,828.00. Following the completion of the transaction, the director owned 8,411 shares in the company, valued at $357,299.28. This represents a 38.77% increase in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Anelise Angelino Sacks acquired 2,000 shares of the business’s stock in a transaction dated Monday, February 9th. The shares were bought at an average price of $41.25 per share, with a total value of $82,500.00. Following the transaction, the director directly owned 5,403 shares in the company, valued at approximately $222,873.75. The trade was a 58.77% increase in their position. The SEC filing for this purchase provides additional information. Over the last three months, insiders have bought 8,145 shares of company stock valued at $332,233.

Institutional Investors Weigh In On Ralliant

Large investors have recently bought and sold shares of the business. Aberdeen Group plc bought a new position in Ralliant during the second quarter valued at about $5,042,000. CWM LLC bought a new position in shares of Ralliant in the 2nd quarter valued at approximately $280,000. Allspring Global Investments Holdings LLC acquired a new stake in Ralliant in the 2nd quarter worth approximately $281,000. Yousif Capital Management LLC bought a new stake in Ralliant during the second quarter worth approximately $2,826,000. Finally, TD Asset Management Inc acquired a new position in Ralliant during the second quarter valued at approximately $13,190,000.

Ralliant Stock Up 3.4%

Shares of Ralliant stock traded up $1.43 on Friday, hitting $44.03. 2,283,937 shares of the company traded hands, compared to its average volume of 2,521,694. Ralliant has a 12-month low of $37.27 and a 12-month high of $57.02. The company has a quick ratio of 0.58, a current ratio of 0.84 and a debt-to-equity ratio of 0.38. The company has a market cap of $4.97 billion and a PE ratio of 22.46. The company has a 50-day moving average price of $50.79 and a 200 day moving average price of $46.56.

Ralliant (NYSE:RAL) last issued its earnings results on Wednesday, February 4th. The company reported $0.69 EPS for the quarter, beating analysts’ consensus estimates of $0.67 by $0.02. The firm had revenue of $554.60 million during the quarter, compared to analysts’ expectations of $543.04 million. The business’s quarterly revenue was up 1.2% compared to the same quarter last year. Ralliant has set its Q1 2026 guidance at 0.460-0.520 EPS and its FY 2026 guidance at 2.220-2.420 EPS.

Ralliant Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Monday, March 23rd. Stockholders of record on Monday, March 9th will be paid a dividend of $0.05 per share. The ex-dividend date is Monday, March 9th. This represents a $0.20 annualized dividend and a dividend yield of 0.5%. Ralliant’s dividend payout ratio is 10.20%.

Key Headlines Impacting Ralliant

Here are the key news stories impacting Ralliant this week:

• Positive Sentiment: Directors/insiders bought stock this week (Kate Mitchell bought 2,350 shares at ~$42.48; Anelise Angelino Sacks bought ~2,000 shares), a signal often read as confidence in the company and a near‑term support for the share price. InsiderTrades: Kate Mitchell Acquires 2,350 Shares The Motley Fool: Director Scoops Up 2,000 Shares
• Neutral Sentiment: Recent quarterly results beat consensus (EPS and revenue) and the company provided Q1 and FY 2026 guidance — fundamentals remain mixed and will be watched closely but are not a new surprise. MarketBeat: Ralliant Earnings & Guidance
• Negative Sentiment: Multiple law firms have publicly opened or promoted investigations into possible securities‑law violations tied to Ralliant (Kaplan Fox, Kirby McInerney, Kessler Topaz, Block & Leviton and others). Those actions increase litigation and regulatory risk and can pressure the stock as legal costs, disclosures and management distraction unfold. Globe and Mail: Kaplan Fox Alert GlobeNewswire: Kirby McInerney Alert
• Negative Sentiment: Ongoing negative analyst moves, higher short interest and prior material non‑cash impairment/guidance reductions (reported earlier) raise downside risk and intraday volatility — these factors can offset positive insider signals and lead to further selling on adverse updates. Kessler Topaz PR Business Insider: Block & Leviton Alert

Ralliant Company Profile

Ralliant, Inc (NYSE: RAL) is a medical technology company focused on enabling point-of-care cell therapy solutions in the field of regenerative medicine. The company develops and markets systems that isolate, concentrate and store adipose-derived stromal vascular fraction (SVF) cells directly from a patient’s own fat tissue, facilitating same-day, autologous treatments without the need for extensive laboratory infrastructure.

The company’s core product portfolio includes proprietary device platforms and single-use processing kits engineered to streamline the workflow for clinicians.